Protein Assays Market Research Report- Global Forecast till 2027

Protein Assays Market Research Report By Type (Copper-Ion-Based Assays, Test Strip-Based Assays, Dye-Binding Assays), Application (Diagnosis, Drug Discovery, Protein Purification), Product (reagents & kits, instruments and others), Technology (colorimetric-based protein assays, fluorescence-based protein assays, and absorbance-based protein assays), End User (hospitals & diagnostic centers, academic institutes, pharmaceutical & biotechnology companies and others) - Forecast till 2027

ID: MRFR/LS/3655-HCR | February 2021 | Region: Global | 120 pages

Protein Assays Market Scenario


Protein assays are utilized in life science research to detect the presence of protein in a sample. There are various assays available in the market differing from each other on the basis of sensitivity, principle and methodology. The macro factors such as sample size, amount, interfering agents and reproducibility are also responsible for its quantification. Protein assays rely mostly on color change i.e. colorimetric assay and use of standard protein such as immunoglobulin G (IgG) or bovine serum albumin (BSA). Protein quantification is the most important step before separation and analysis by electrophoresis or chromatography or any other immunochemical techniques.


The use of protein assays for early diagnosis of diseases such as cancer and HIV may significantly reduce the morbidity and mortality of the disease. These assays are cost effective, facile and reproducible. Commonly used protein assay are Bradford, Lowry, BCA, and UV spectroscopic protein assays. Thus, use of assay in disease diagnosis, drug discovery and development encourages the biotechnology and pharmaceutical industry to invest in R&D, which fuels the demand of protein assays market.


Several new biomarker identification systems are launched by the key players which grants various opportunities for the protein assay market. For instance, in June 2017, Gyros Protein Technologies AB launched a new version of its anti-drug antibody (ADA) solution for the immunogenicity market. This solution enables customers to automatically run the assays in a time-efficient manner using small volumes of patient samples and reagents, and shorten run-times.


According to a publication by Pharmaceuticals Research and Manufacturers of America (PhRMA), the organizations spent approximately $58.8 billion on R&D in 2015 accounted for the largest part of all the biopharmaceutical R&D spending in the U.S. However, high cost of multiplex assay hardware is limiting the growth of protein assay market.


The protein assays market is expected to grow at a CAGR of approximately 10.8% during the forecast period 2017-2023.


Intended Audience



  • Protein Assays Suppliers

  • Protein Assays Manufacturers

  • Research And Development (R&D) Companies

  • Medical Research Laboratories

  • Academic Medical Institutes and Universities


Segmentation


The protein assays is segmented on the basis of type, application, product, technology and end-users.


On the basis of type, the protein assays market is segmented into copper-ion-based assays, test strip-based assays, dye-binding assays, and others 


On the basis of application, the protein assays market is segmented into diagnosis, drug discovery, protein purification and others


On the basis of product, the protein assays market is segmented into reagents & kits, instruments and others


On the basis of technology, the protein assays market is segmented into colorimetric-based protein assays, fluorescence-based protein assays, and absorbance-based protein assays


On the basis of end-user, the protein assays market is segmented into hospitals & diagnostic centers, academic institutes, pharmaceutical & biotechnology companies and others.


Regional Analysis


The protein assays market consists of countries namely America, Europe, Asia Pacific, and the Middle East.


North America is projected to hold the largest share of the protein assay market due to presence of superior research and development base, strong regional economics, and greater emphasis on disease prevention and wellness by governments.


The European protein assay market is expected to witness rapid growth owing to the high investment in various private and government funded research and development programs in the region and increased spending on pharmaceutical and biotechnology industry development.


Countries such as China, Japan, and India in Asia Pacific are also poised to be promising markets for protein assay in the near future. The healthcare expenditure in Asia increased due to an extension of state health care programs and the increasing affluence of the population. India is anticipated to witness an expansion in spending due to a government resolution to enhance healthcare services. Moreover, China and South Korea are striving to develop their biotechnology sector for diagnosis purpose. China’s efforts to develop its biotech sector has shown good results in sectors such as vaccines and biological products and the same can be expected in the protein assays industry. However, low research and development (R&D) yields, high infrastructure cost, stringent regulatory framework, and lack of trained resources are some of the restraints of the protein assay market.


The Middle East region is expected to grow at a faster rate due to the factors such as the extensive development of health care infrastructure and growing emphasis on research and development in the health care sector.


Key Players


Many new companies have jumped into the market in order to make the most out of the opportunities. Companies are implementing the strategies of mergers and acquisitions with other players. For instance, in June 2015, Thermo Fisher Scientific Inc. introduced the Orbitrap Fusion Lumos Tribrid mass spectrometer and updated the device in 2017.


Some of key the players in the protein assays market are GE Healthcare (U.S.), Thermo Fisher Scientific (U.S.), Bio-Rad Laboratories Inc. (U.S.), Merck KGaA (Germany), Cell Signaling Technology Inc. (U.S.), Abcam plc (U.S.), Lucigen Corporation (U.S.), PerkinElmer Inc. (U.S.), QIAGEN (Germany), Lonza Group Ltd. (Switerzland), Bio-Techne (U.S.), BioVision Inc. (U.S.), Illumina Inc. (U.S.), New England Biolabs (U.S.), Takara Bio Inc. (Japan), Promega Corporation (U.S.), F. Hoffmann-La Roche Ltd (Switerzland), and others.


Research Methodology Protein Assays Market


Sources: Annual reports, Press release, White paper, and Company presentation



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   10.8% (2017-2023)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, Application, Product, Technology and End-users
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   GE Healthcare (U.S.), Thermo Fisher Scientific (U.S.), Bio-Rad Laboratories Inc. (U.S.), Merck KGaA (Germany), Cell Signaling Technology Inc. (U.S.), Abcam plc (U.S.), Lucigen Corporation (U.S.), PerkinElmer Inc. (U.S.), QIAGEN (Germany), Lonza Group Ltd. (Switerzland), Bio-Techne (U.S.), BioVision Inc. (U.S.), Illumina Inc. (U.S.), New England Biolabs (U.S.), Takara Bio Inc. (Japan), Promega Corporation (U.S.), F. Hoffmann-La Roche Ltd (Switerzland), and others
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • Use of assay in disease diagnosis
  • Drug discovery and development


  • Frequently Asked Questions (FAQ) :


    Protein Assays Market is expected to expand at 10.8% CAGR from 2017 to 2023.

    Early detection of diseases at a preventive stage is the primary driver of the Protein Assays Market.

    High costs of multiplex assay hardware is the major factor expected to impede the Protein Assays Market growth.

    North America is expected to dominate in the protein assays market till 2023.

    F. Hoffmann-La Roche Ltd, Abcam plc, PerkinElmer Inc., QIAGEN, GE Healthcare, BioVision Inc., Cell Signaling Technology Inc., Illumina Inc., Thermo Fisher Scientific, Bio-Rad Laboratories Inc., Lucigen Corporation, New England Biolabs, Promega Corporation, Takara Bio Inc., Merck KGaA, Lonza Group Ltd., and Bio-Techne are prominent players of the Protein Assays Market.

    TABLE OF CONTENT

    Chapter 1. Report Prologue

    Chapter 2. Market Introduction

    2.1 Definition

    2.2 Scope of the Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    Chapter 3. Research Methodology

    3.1 Introduction

    3.2 Primary Research

    3.3 Secondary research

    3.4 Market Size Estimation

    Chapter 4. Market Dynamics

    4.1 Drivers

    4.2 Restrains

    4.3 Opportunities

    4.4 Challenges

    4.5 Macroeconomic Indicators

    4.6 Technology Trends & Assessment

    Chapter 5. Market Factor Analysis

    5.1 Porter’s Five Forces Analysis

    5.1.1 Bargaining Power of Suppliers

    5.1.2 Bargaining Power of Buyers

    5.1.3 Threat of New Entrants

    5.1.4 Threat of Substitutes

    5.1.5 Intensity of Rivalry

    5.2 Value Chain Analysis

    5.3 Investment Feasibility Analysis

    5.4 Pricing Analysis

    Chapter 6. Global Protein Assay Market, by Type Test

    6.1 Introduction

    6.2 Copper-ion-based Assays

    6.2.1 Market Estimates & Forecast, 2020 – 2023

    6.3 Test Strip-based Assays

    6.3.1 Market Estimates & Forecast, 2020 – 2023

    6.4 Dye-binding Assays

    6.4.1 Market Estimates & Forecast, 2020 – 2023

    6.5 Others

    6.5.1 Market Estimates & Forecast, 2020 – 2023

    Chapter 7. Global Protein Assay Market, by Application

    7.1 Introduction

    7.2 Diagnosis

    7.2.1 Market Estimates & Forecast, 2020-2027

    7.3 Drug Discovery

    7.3.1 Market Estimates & Forecast, 2020-2027

    7.4 Protein Purification

    7.4.1 Market Estimates & Forecast, 2020-2027

    7.5 Others

    Chapter 8. Global Protein Assay Market, by Product

    8.1 Introduction

    8.2 Reagents & Kits

    8.2.1 Market Estimates & Forecast, 2020-2027

    8.3 Instruments

    8.3.1 Market Estimates & Forecast, 2020-2027

    8.4 Others

    Chapter 9. Global Protein Assay Market, by Technology

    9.1 Introduction

    9.2 Colorimetric-based Protein Assay

    9.2.1 Market Estimates & Forecast, 2020-2027

    9.3 Fluorescence-based Protein Assays

    9.3.1 Market Estimates & Forecast, 2020-2027

    9.4 Absorbance-based Protein Assays

    9.4.1 Market Estimates & Forecast, 2020-2027

    Chapter 10. Global Protein Assay Market, by End User

    10.1 Introduction

    10.2 Hospitals & Diagnostic Centers

    10.2.1 Market Estimates & Forecast, 2020-2027

    10.3 Academic Institutes

    10.3.1 Market Estimates & Forecast, 2020-2027

    10.4 Pharmaceutical & Biotechnology Companies

    10.4.1 Market Estimates & Forecast, 2020-2027

    10.5 Others

    10.5.1 Market Estimates & Forecast, 2020-2027

    Chapter. 11 Global Protein Assay Market, by Region

    11.1 Introduction

    11.2 Americas

    11.2.1 North America

    11.2.1.1 U.S.

    11.2.1.1 Canada

    11.2.2 South America

    11.3 Europe

    11.3.1 Western Europe

    11.3.1.1 Germany

    11.3.1.2 France

    11.3.1.3 Italy

    11.3.1.4 Spain

    11.3.1.5 U.K

    11.3.1.6 Rest of Western Europe

    11.3.2 Eastern Europe

    11.4 Asia Pacific

    11.4.1 Japan

    11.4.2 China

    11.4.3 India

    11.4.4 Australia

    11.4.5 Republic of Korea

    11.4.6 Rest of Asia Pacific

    11.5 The The Middle East & Africa

    11.5.1 United Arab Emirates

    11.5.2 Saudi Arabia

    11.5.3 Rest of the The Middle East & Africa

    Chapter 12 Company Landscape

    12.1 Introduction

    12.2 Market Share Analysis

    12.3 Key Development & Strategies

    12.3.1 Key Developments

    Chapter 13 Company Profiles

    13.1 GE Healthcare

    13.1.1 Company Overview

    13.1.2 Product Overview

    13.1.3 Financials

    13.1.4 SWOT Analysis

    13.2 Thermo Fisher Scientific

    13.2.1 Company Overview

    13.2.2 Product Overview

    13.2.3 Financial Overview

    13.2.4 Key Developments

    13.2.5 SWOT Analysis

    13.3 Bio-Rad Laboratories Inc.

    13.3.1 Company Overview

    13.3.2 Product Overview

    13.3.3 Financial Overview

    13.3.4 Key Development

    13.3.5 SWOT Analysis

    13.4 Merck KGaA

    13.4.1 Company Overview

    13.4.2 Product/Business Segment Overview

    13.4.3 Financial Overview

    13.4.4 Key Development

    13.4.5 SWOT Analysis

    13.5 PerkinElmer Inc.

    13.5.1 Company Overview

    13.5.2 Product Overview

    13.5.3 Financial overview

    13.5.4 Key Developments

    13.6 QIAGEN

    13.6.1 Company Overview

    13.6.2 Product Overview

    13.6.3 Financial Overview

    13.6.4 Key Developments

    13.7 BioVision Inc.

    13.7.1 Overview

    13.7.2 Product Overview

    13.7.3 Financials

    13.7.4 Key Developments

    13.7.5 SWOT Analysis

    13.8 F. Hoffmann-La Roche Ltd

    13.8.1 Company Overview

    13.8.2 Product/Business Segment Overview

    13.8.3 Financial Overview

    13.8.4 Key Development

    13.8.5 SWOT Analysis

    13.9 Illumina Inc.

    13.9.1 Company Overview

    13.9.2 Product Overview

    13.9.3 Financial overview

    13.9.4 Key Developments

    13.10 Others

    Chapter 14 MRFR Conclusion

    14.1 Key Findings

    14.1.1 From CEO’s View Point

    14.1.2 Unmet Needs of the Market

    14.2 Key Companies to Watch

    14.3 Prediction of Pharmaceutical industry

    Chapter 15 Appendix

    LIST OF TABLES

    Table 1 Protein Assay Industry Synopsis, 2020-2027

    Table 2 Protein Assay Market Estimates and Forecast, 2020-2027, (USD Million)

    Table 3 Protein Assay Market by Region, 2020-2027, (USD Million)

    Table 4 Protein Assay Market by Type, 2020-2027, (USD Million)

    Table 5 Protein Assay Market by Application, 2020-2027, (USD Million)

    Table 6 Protein Assay Market by Product, 2020-2027, (USD Million)

    Table 7 Protein Assay Market by Technology, 2020-2027, (USD Million)

    Table 8 Protein Assay Market by End Users, 2020-2027, (USD Million)

    Table 9 North America Protein Assay Market by Type, 2020-2027, (USD Million)

    Table 10 North America Protein Assay Market by Application, 2020-2027, (USD Million)

    Table 11 North America Protein Assay Market by Product, 2020-2027, (USD Million)

    Table 12 North America Protein Assay Market by Technology, 2020-2027, (USD Million)

    Table 13 North America Protein Assay Market by End User, 2020-2027, (USD Million)

    Table 14 US Protein Assay Market by Type, 2020-2027, (USD Million)

    Table 15 US Protein Assay Market by Application, 2020-2027, (USD Million)

    Table 16 US Protein Assay Market by Product, 2020-2027, (USD Million)

    Table 17 US Protein Assay Market by Technology, 2020-2027, (USD Million)

    Table 18 US Protein Assay Market by End User, 2020-2027, (USD Million)

    Table 19 Canada Protein Assay Market by Type, 2020-2027, (USD Million)

    Table 20 Canada Protein Assay Market by Application, 2020-2027, (USD Million)

    Table 21 Canada Protein Assay Market by Product, 2020-2027, (USD Million)

    Table 22 Canada Protein Assay Market by Technology, 2020-2027, (USD Million)

    Table 23 Canada Protein Assay Market by End User, 2020-2027, (USD Million)

    Table 24 South America Protein Assay Market by Type, 2020-2027, (USD Million)

    Table 25 South America Protein Assay Market by Application, 2020-2027, (USD Million)

    Table 26 South America Protein Assay Market by Product, 2020-2027, (USD Million)

    Table 27 South America Protein Assay Market by Technology, 2020-2027, (USD Million)

    Table 28 South America Protein Assay Market by End User, 2020-2027, (USD Million)

    Table 29 Europe Protein Assay Market by Type, 2020-2027, (USD Million)

    Table 30 Europe Protein Assay Market by Application, 2020-2027, (USD Million)

    Table 31 Europe Protein Assay Market by Product, 2020-2027, (USD Million)

    Table 32 Europe Protein Assay Market by Technology, 2020-2027, (USD Million)

    Table 33 Europe Protein Assay Market by End User, 2020-2027, (USD Million)

    Table 34 Western Europe Protein Assay Market by Type, 2020-2027, (USD Million)

    Table 35 Western Europe Protein Assay Market by Application, 2020-2027, (USD Million)

    Table 36 Western Europe Protein Assay Market by Product, 2020-2027, (USD Million)

    Table 37 Western Europe Protein Assay Market by Technology, 2020-2027, (USD Million)

    Table 38 Western Europe Protein Assay Market by End User, 2020-2027, (USD Million)

    Table 39 Eastern Europe Protein Assay Market by Type, 2020-2027, (USD Million)

    Table 40 Eastern Europe Protein Assay Market by Application, 2020-2027, (USD Million)

    Table 41 Eastern Europe Protein Assay Market by Product, 2020-2027, (USD Million)

    Table 42 Eastern Europe Protein Assay Market by Technology, 2020-2027, (USD Million)

    Table 43 Eastern Europe Protein Assay Market by End User, 2020-2027, (USD Million)

    Table 44 Asia Pacific Protein Assay Market by Type, 2020-2027, (USD Million)

    Table 45 Asia Pacific Protein Assay Market by Application, 2020-2027, (USD Million)

    Table 46 Asia Pacific Protein Assay Market by Product, 2020-2027, (USD Million)

    Table 47 Asia Pacific Protein Assay Market by Technology, 2020-2027, (USD Million)

    Table 48 Asia Pacific Protein Assay Market by End User, 2020-2027, (USD Million)

    Table 49 The Middle East & Africa Protein Assay Market by Type, 2020-2027, (USD Million)

    Table 50 The Middle East & Africa Protein Assay Market by Application, 2020-2027, (USD Million)

    Table 51 The Middle East & Africa Protein Assay Market by Product, 2020-2027, (USD Million)

    Table 52 The Middle East & Africa Protein Assay Market by Technology, 2020-2027, (USD Million)

    Table 53 The Middle East & Africa Protein Assay Market by End User, 2020-2027, (USD Million)

    LIST OF FIGURES

    Figure 1 Research Process

    Figure 2 Segmentation for Protein Assay Market

    Figure 3 Segmentation Market Dynamics for Protein Assay Market

    Figure 4 Global Protein Assay Market Share, by Type 2020

    Figure 5 Global Protein Assay Market Share, by Application 2020

    Figure 6 Global Protein Assay Market Share, by Product, 2020

    Figure 8 Global Protein Assay Market Share, by Technology, 2020

    Figure 9 Global Protein Assay Market Share, by End Users, 2020

    Figure 10 Global Protein Assay Market Share, by Region, 2020

    Figure 11 North America Protein Assay Market Share, by Country, 2020

    Figure 12 Europe Protein Assay Market Share, by Country, 2020

    Figure 13 Asia Pacific Protein Assay Market Share, by Country, 2020

    Figure 14 The Middle East & Africa Protein Assay Market Share, by Country, 2020

    Figure 15 Global Protein Assay Market: Company Share Analysis, 2020 (%)

    Figure 16 GE Healthcare: Key Financials

    Figure 17 GE Healthcare: Segmental Revenue

    Figure 18 GE Healthcare: Geographical Revenue

    Figure 19 Thermo Fisher Scientific: Key Financials

    Figure 20 Thermo Fisher Scientific: Segmental Revenue

    Figure 21 Thermo Fisher Scientific: Geographical Revenue

    Figure 22 Bio-Rad Laboratories Inc.: Key Financials

    Figure 23 Bio-Rad Laboratories Inc.: Segmental Revenue

    Figure 24 Bio-Rad Laboratories Inc.: Geographical Revenue

    Figure 25 Merck KGaA: Key Financials

    Figure 26 Merck KGaA: Segmental Revenue

    Figure 27 Merck KGaA: Geographical Revenue

    Figure 28 PerkinElmer Inc.: Key Financials

    Figure 29 PerkinElmer Inc.: Segmental Revenue

    Figure 30 PerkinElmer Inc.: Geographical Revenue

    Figure 32 QIAGEN: Key Financials

    Figure 33 QIAGEN: Segmental Revenue

    Figure 34 QIAGEN: Geographical Revenue

    Figure 35 BioVision Inc.: Key Financials

    Figure 36 BioVision Inc.: Segmental Revenue

    Figure 37 BioVision Inc.: Geographical Revenue

    Figure 38 F. Hoffmann-La Roche Ltd: Key Financials

    Figure 39 F. Hoffmann-La Roche Ltd: Segmental Revenue

    Figure 40 F. Hoffmann-La Roche Ltd: Geographical Revenue

    Figure 41 Illumina Inc.: Key Financials

    Figure 42 Illumina Inc.: Segmental Revenue

    Figure 43 Illumina Inc.: Geographical Revenue